Edward Vincent Loftus, Jr, MD


  • 28262 Citations
  • 84 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Crohn Disease Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Sclerosing Cholangitis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Population Medicine & Life Sciences
Colitis Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Steinhart, A. H., Panaccione, R., Targownik, L., Bressler, B., Khanna, R., Marshall, J. K., Afif, W., Bernstein, C. N., Bitton, A., Borgaonkar, M., Chauhan, U., Halloran, B., Jones, J., Kennedy, E., Leontiadis, G. I., Loftus, Jr, E. V., Meddings, J., Moayyedi, P., Murthy, S., Plamondon, S. & 4 othersRosenfeld, G., Schwartz, D., Seow, C. H. & Williams, C., Jan 1 2019, In : Inflammatory bowel diseases. 25, 1, p. 1-13 13 p.

Research output: Contribution to journalArticle

Practice Guidelines
Crohn Disease
13 Citations

ACG Clinical Guideline: Management of Crohn's Disease in Adults

Lichtenstein, G. R., Loftus, Jr, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B. & Sands, B. E., Apr 1 2018, In : American Journal of Gastroenterology. 113, 4, p. 481-517 37 p.

Research output: Contribution to journalReview article

Crohn Disease
Advisory Committees
Standard of Care
Practice Guidelines
4 Citations

Antibiotic use and new-onset inflammatory bowel disease in Olmsted county, Minnesota: A population-based case-control study

Aniwan, S., Tremaine, W. J., Raffals, L. E. H., Kane, S. V. & Loftus, Jr, E. V., Jan 24 2018, In : Journal of Crohn's and Colitis. 12, 2, p. 137-144 8 p., jjx135.

Research output: Contribution to journalArticle

Inflammatory Bowel Diseases
Case-Control Studies
Anti-Bacterial Agents
Logistic Models
1 Citations

A phase 2, randomized, placebo-controlled study evaluating matrix metalloproteinase-9 inhibitor, andecaliximab, in patients with moderately to severely active Crohn's disease

Schreiber, S., Siegel, C. A., Friedenberg, K. A., Younes, Z. H., Seidler, U., Bhandari, B. R., Wang, K., Wendt, E., McKevitt, M., Zhao, S., Sundy, J. S., Lee, S. D. & Loftus, Jr, E. V., Aug 29 2018, In : Journal of Crohn's and Colitis. 12, 9, p. 1014-1020 7 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinase 9
Crohn Disease
Subcutaneous Injections

Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity

Morris, M. W., Stewart, S. A., Heisler, C., Sandborn, W. J., Loftus, Jr, E. V., Zello, G. A., Fowler, S. A. & Jones, J. L., Jan 18 2018, In : Inflammatory bowel diseases. 24, 2, p. 277-285 9 p.

Research output: Contribution to journalArticle

Crohn Disease
Leukocyte L1 Antigen Complex
Area Under Curve
Patient Reported Outcome Measures